Relationship of Serum Prostate Specific Antigen with Hirsutism in Women Having Polycystic Ovary Syndrome Belonging to the Province of Khyber Pakhtunkhwa, Pakistan
Keywords:
Prostate Specific Antigen, Hirsutism, Polycystic Ovary SyndromeAbstract
Objective: To find the relationship of serum PSA with Hirsutism in PCOS females of Khyber Pakhtunkhwa.
Methodology: It was a cross-sectional/comparative study. This study was conducted in Khyber Teaching Hospital, Lady Reading Hospital, and Hayatabad Medical Complex from June to December 2021. A total of 172 study subjects were involved in this study. Serum PSA, testosterone and DHEAS levels of 86 newly diagnosed cases of PCOS (Group A) were compared with 86 healthy age-matched controls (Group B). These parameters were estimated using the ELISA method. Distribution of Hirsutism of the study subjects was also established with FGS. SPSS version 21 was used to analyze the data.
Results: The results showed that serum PSA significantly increased (0.325±0.243 Vs 0.119±0.209, P <0.0001) in females with PCOS. Serum total testosterone (1.639±0.773 vs 0.739±0.965, P<0.0001) and DHEAS (3.397±1.243 Vs 2.035±1.203, P <0.0001) levels were also raised. A highly significant positive relationship was seen between PSA with Hirsutism through FGS (r 0-609, P 0.000), testosterone (r 0.352, P 0.000) and DHEAS levels (r 0.432, P 0.000)
Conclusion: This study observed significantly high PSA correlating positively with Hirsutism in females with PCOS.
Keywords: Prostate Specific Antigen, Hirsutism, Polycystic Ovary Syndrome
References
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011; 7(4): 219-231. doi: 10.1038/nrendo.2010. 217. Epub 2011 Jan 25.
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018; 110(3): 364-379. doi: 10.1016/j.fertnstert.2018.05.004. Epub 2018 Jul 19.
Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016; 2: 16057. doi: 10.1038/nrdp.2016.57.
Horowitz E, Weissman A. The stair-step approach in treatment of anovulatory PCOS patients. Ther Adv Reprod Health. 2020; 14: 26334941209088 18. doi: 10.1177/2633494120908818.
Hanamura T, Ohno K, Hokibara S, Murasawa H, Nakamura T, Watanabe H et al. Clinical significance of serum PSA in breast cancer patients. BMC Cancer. 2019; 19(1): 1021.
doi: 10.1186/s12885-019-6256-2.
Musrap N, Diamandis EP. Prostate-specific antigen as a marker of Hyperandrogenism in omen and its implications for antidoping. Clin Chem. 2016; 62(8): 1066-74. doi: 10.1373/clinchem.2016.256198. Epub 2016 Jun 3.
Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin. Endocrinol. 2004; 60(1): 1-17. doi: 10.1046/j. 1365-2265.2003.01842.
Spritzer PM, Barone CR, Oliveira FB. Hirsutism in polycystic ovary syndrome: pathophysiology and management. Curr Pharm Des. 2016; 22(36): 5603-13. doi: 10.2174/1381612822666160720151 243.
Randall VA. Androgens and hair growth. Dermatol. Ther. 2008; 21(5): 314-28.
doi: 10.1111/j.1529-8019.2008.00214.x.
Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring Hirsutism. Hum Reprod Update. 2009; 16(1): 51-64. doi: 10.1093/humupd/dmp 024.
Ilagan MKCC, Paz-Pacheco E, Totesora DZ, Clemente-Chua LR, Jalique JRK. The Modified Ferriman-Gallwey Score and Hirsutism among Filipino Women. Endocrinol Metab(Seoul). 2019; 34(4): 374-381. doi: 10.3803/EnM.2019.34.4.374.
Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961; 21(11): 1440-7. doi: 10.1210/jcem-21-11-1440.
Spritzer PM, Marchesan LB, Santos BR, Fighera TM. Hirsutism, normal androgens and diagnosis of PCOS. Diagnostics (Basel). 2022; 12(8): 1922. doi: 10.3390/diagnostics12081922.
Kurtoglu G, Emre S, Metin A, Ergin M, Erel O, Aktas A. Serum prostate-specific antigen levels in women with androgenic alopecia. Turkderm-Turk Arch Dermatol Venereology 2019; 53: 1-6. doi: 10.4274/turkderm.galenos.2018.25492.
Nadir A, Temikan S, Ozderya A, Temizkan O, Orbay E, Aydin K. Dehydroepiandrosterone sulphate/ free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome. Gynecol Endocrinol. 2019; 35(2): 128-132. doi: 10.1080/09513590. 2018.1505843. Epub 2018 Oct 16.
Banu H, Hasanat MA, Akhtar N, Shah S, Sultana T, Tuqan S et al. Prostate specific antigen is raised in polycystic ovary syndrome. Endocrinol Metab Int J. 2018; 6(4): 297-300. doi: 10.15406/emij.2018.06.00192.
ZH Wu, Y Tang, X Niu, FF Pu, XY Xiao, W Kong. Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis. Wu ZH, Tang Y, Niu X, Pu F, Xiao XY, Kong W. J Ovarian Res. 2019; 12: 94. doi: 10.1186/s13048-019-0569-2.
Radowicki S, Kunicki M, Bandurska-Stankiewicz E. Prostate-specific antigen in the serum of women with benign breast disease. Eur J Obstet Gynecol Reprod Biol. 2008; 138(2): 212-6. doi: 10.1016/j.ejogrb.2007.05.023. Epub 2007 Sep 11.
Duraker N, Can D, Parilti M. Measurement of serum total and free prostate specific antigen in women with colorectal carcinoma. Br J Cancer. 2002; 86(2): 203-6. doi: 10.1038/sj.bjc.6600049.
Vural B, Ozkan S, Bodur H. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome? J Obstet Gynaecol Res. 2007; 33(2): 166-73. doi: 10.1111/j.1447-0756.2007.00507.x.
Ibrahim WW, Salah RK, Abbas WM. Serum prostate specific antigen level in women with polycystic ovary syndrome. Fac Med Baghdad. 2016; 58(2): 136-9.
Ukinc K, Ersoz HO, Erem C, Hacihasanoglu AB. Diagnostic value of prostate-specific antigen (PSA) and free prostate-specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome. Endocrine. 2009; 35(1): 123-9. doi: 10.1007/s12020-008-9130-6. Epub 2008
Nov 14.
Rudnicka E, Radowicki S, Suchta K. Prostate-specific antigen (PSA) in diagnosis of polycystic ovarian syndrome a new insight. Gynecol Endocrinol. 2016; 32(11): 931-5. doi: 10.1080/ 09513590.2016.1200552. Epub 2016 Jul 16.
Tokmark A, Bodur S, Erkilinc S, Ozel S, Engin-Ustun Y. The value of prostate-specific antigen in diagnosis of polycystic ovarian syndrome in adolescent girls. J Pediatr Adolesc Gynecol. 2018; 31(3): 263-9. doi: 10.1016/j.jpag.2017.11.004. Epub 2017 Nov 21.
Nagaraj S, Naik AL, Pratibha K, Kumar VK. Prostate specific antigen in women with PCOS and its correlation with total testosterone. Int J Biotech Biochem. 2019; 15(2): 87-95.
Bhat K, Bhandari M, Garg V. Prostate specific antigen: a diagnostic marker in polycystic ovarian syndrome. J Clin Diagnostic Res. 2019; 13(1): BC14-BC16.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Liaquat University of Medical & Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Submission of a manuscript to the journal implies that all authors have read and agreed to the content of the undertaking form or the Terms and Conditions.
When an article is accepted for publication, the author(s) retain the copyright and are required to grant the publisher the right of first publication and other non-exclusive publishing rights to JLUMHS.
Articles published in the Journal of Liaquat University of Medical & health sciences are open access articles under a Creative Commons Attribution-Noncommercial - Share Alike 4.0 License. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. This is in accordance with the BOAI definition of open access. In addition to that users are allowed to remix, tweak and build upon the work non-commercially as long as appropriate credit is given and the new creations are licensed under the identical terms. Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.